In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
Bio-hybrid robot made from langoustine shells works like arcade claw crane
In Switzerland, scientists at École Polytechnique Fédérale de Lausanne have converted shellfish shells into claws that grip, not unlike the prize-filled claw machines found...
Holy Carp! makes waves as biodegradable single-use soy sauce alternative
In Australia, design studios Heliograf and Vert Design have jointly developed a biodegradable alternative to whimsical—but polluting—plastic fish-shaped soy sauce containers often seen with...
Pineapple hair ties win Fowler Business Concept Challenge
In California, a University of San Diego graduate student has won a $15,000 scholarship to advance her pineapple leaf hair ties.
Sage Dobby, who...